A whistleblower complaint and interviews with current and former federal agents are raising new questions about how the Drug Enforcement Administration handled fentanyl investigations in New Mexico, with allegations that authorities monitored shipments of the deadly synthetic opioid for years without seizing them before they reached local communities.
The allegations, reported by The Associated Press, center on DEA operations conducted between 2023 and 2025. According to three current and former DEA agents cited by the AP, investigators tracked multiple fentanyl transactions and shipments while pursuing larger trafficking networks, yet thousands of pills were allegedly allowed to circulate despite law enforcement awareness of the deals.
The controversy arrives as fentanyl remains one of the most pressing public health and law enforcement challenges in the United States. According to the Centers for Disease Control and Prevention, synthetic opioids continue to drive the majority of overdose deaths nationwide, making decisions about enforcement tactics particularly sensitive.
"We poisoned our community to make cases," DEA Special Agent David Howell told the AP. "Through our own willful blindness, we get to say, 'We don't really know what happened to the drugs.' But we 100% got people killed."
The allegations focus on a long-established investigative strategy often used against organized drug trafficking groups. Rather than immediately intercepting every shipment, agents sometimes allow narcotics transactions to proceed while gathering intelligence, identifying higher-level targets, and building broader conspiracy cases.
That approach has historically been used in investigations involving cocaine, heroin, methamphetamine, and other narcotics. Critics argue fentanyl presents a fundamentally different challenge because of its extraordinary potency and its role in the overdose epidemic.
The CDC states that fentanyl is approximately 50 times more potent than heroin and 100 times stronger than morphine.
The agency warns:
- "Synthetic opioids like fentanyl contribute to nearly 70% of overdose deaths. Even in small doses, it can be deadly."
- "Drugs may contain deadly levels of fentanyl, and you wouldn't be able to see it, taste it, or smell it."
- "It is nearly impossible to tell if drugs have been mixed with fentanyl unless you test your drugs with fentanyl test strips."
Those warnings have fueled criticism from some agents and public health advocates who question whether traditional investigative methods remain appropriate when dealing with a substance capable of causing fatal overdoses from extremely small quantities.
Federal prosecutors and law enforcement officials have defended the broader rationale behind complex trafficking investigations. The goal, they argue, is to dismantle entire criminal organizations rather than repeatedly arrest low-level distributors while larger networks continue operating.
Alex Uballez, who served as U.S. attorney in New Mexico from 2022 until last year, acknowledged the practice while defending the importance of targeting major traffickers.
"The bigger fish are worth catching, and that will save more lives," Uballez told the AP.
Supporters of that strategy point to significant enforcement successes. Last year, authorities announced what the DEA described as the largest fentanyl seizure in Albuquerque's history, highlighting the scale of trafficking operations that investigators say require lengthy and sophisticated investigations to dismantle.
The DEA strongly disputed claims that it knowingly allowed fentanyl to enter communities unchecked.
In a statement provided to the AP, the agency said, "Public descriptions suggesting that DEA knowingly permitted fentanyl to reach communities are false and fundamentally mischaracterize the facts."
The agency further stated that the investigations involved court-approved surveillance operations.
According to the DEA, agents and prosecutors conducted "real-time surveillance, intelligence gathering, and operational analysis targeting larger drug trafficking organizations" through authorized wiretap investigations.
